1. Home
  2. TRVI vs MSB Comparison

TRVI vs MSB Comparison

Compare TRVI & MSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • MSB
  • Stock Information
  • Founded
  • TRVI 2011
  • MSB 1961
  • Country
  • TRVI United States
  • MSB United States
  • Employees
  • TRVI N/A
  • MSB N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • MSB Metal Mining
  • Sector
  • TRVI Health Care
  • MSB Basic Materials
  • Exchange
  • TRVI Nasdaq
  • MSB Nasdaq
  • Market Cap
  • TRVI 725.7M
  • MSB 320.9M
  • IPO Year
  • TRVI 2019
  • MSB N/A
  • Fundamental
  • Price
  • TRVI $6.89
  • MSB $24.90
  • Analyst Decision
  • TRVI Strong Buy
  • MSB
  • Analyst Count
  • TRVI 9
  • MSB 0
  • Target Price
  • TRVI $19.94
  • MSB N/A
  • AVG Volume (30 Days)
  • TRVI 1.6M
  • MSB 35.9K
  • Earning Date
  • TRVI 08-07-2025
  • MSB 01-01-0001
  • Dividend Yield
  • TRVI N/A
  • MSB 27.83%
  • EPS Growth
  • TRVI N/A
  • MSB 335.65
  • EPS
  • TRVI N/A
  • MSB 7.12
  • Revenue
  • TRVI N/A
  • MSB $25,894,592.00
  • Revenue This Year
  • TRVI N/A
  • MSB N/A
  • Revenue Next Year
  • TRVI N/A
  • MSB N/A
  • P/E Ratio
  • TRVI N/A
  • MSB $3.48
  • Revenue Growth
  • TRVI N/A
  • MSB N/A
  • 52 Week Low
  • TRVI $2.36
  • MSB $15.93
  • 52 Week High
  • TRVI $7.48
  • MSB $37.00
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 64.54
  • MSB 50.76
  • Support Level
  • TRVI $5.41
  • MSB $24.00
  • Resistance Level
  • TRVI $6.08
  • MSB $25.67
  • Average True Range (ATR)
  • TRVI 0.32
  • MSB 0.97
  • MACD
  • TRVI 0.14
  • MSB 0.17
  • Stochastic Oscillator
  • TRVI 89.91
  • MSB 74.76

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About MSB Mesabi Trust

Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.

Share on Social Networks: